imiquimod has been researched along with Adjuvant Arthritis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acinas, O; Alvarez, P; Augustín, JJ; Genre, F; Iglesias, M; Mendiguren, MA; Merino, J; Merino, R; San Segundo, D; Tamayo, E; Vázquez, JA | 1 |
| Alsaleh, G; Bahram, S; Blüml, S; Chan, S; Flacher, V; Georgel, P; Holcmann, M; Kastner, P; Kirstetter, P; Mariotte, A; Mueller, C; Nehmar, R; Niederreiter, B; Puchner, A; Saferding, V; Schabbauer, G; Sibilia, J; Vandamme, T; Voisin, B | 1 |
| Amiaud, J; Bart, G; Blanchard, F; Bourreille, A; Boutet, MA; Brulin, B; Charrier, C; Gabay, C; Le Goff, B; Lecron, JC; Morel, F; Palmer, G; Penhoat, M; Rolli-Derkinderen, M; Vigne, S | 1 |
| Blackshear, PJ; Curtis, AD; Flake, GP; Hill, GD; Lai, WS; Mannie, MD; Patial, S; Stumpo, DJ | 1 |
| Athari, SK; Bessis, N; Biton, J; Boissier, MC; Caux, F; Girard, JP; Herbelin, A; Hervé, R; Lemeiter, D; Poirier, E; Raffaillac, A; Semerano, L | 1 |
5 other study(ies) available for imiquimod and Adjuvant Arthritis
| Article | Year |
|---|---|
Therapeutic Effects of Anti-Bone Morphogenetic Protein and Activin Membrane-Bound Inhibitor Treatment in Psoriasis and Arthritis.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Monoclonal; Arthritis, Experimental; Arthritis, Psoriatic; CD4-Positive T-Lymphocytes; Cell Differentiation; Collagen Type II; Disease Models, Animal; Imiquimod; Interleukin-17; Interleukin-2; Mannans; Membrane Proteins; Mice; Mice, Knockout; Psoriasis; Saccharomyces cerevisiae; Skin; T-Lymphocytes, Regulatory; Th17 Cells; Transforming Growth Factor beta | 2020 |
Therapeutic Modulation of Plasmacytoid Dendritic Cells in Experimental Arthritis.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Cytokines; Dendritic Cells; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Gene Expression Profiling; Humans; Ikaros Transcription Factor; Imiquimod; Interferon Type I; Membrane Glycoproteins; Mice; Mice, Knockout; Mice, Transgenic; Reverse Transcriptase Polymerase Chain Reaction; Toll-Like Receptor 7; Tumor Necrosis Factor-alpha | 2017 |
Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease.
Topics: Aminoquinolines; Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Caco-2 Cells; Cell Line; Crohn Disease; Dendritic Cells; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Humans; Imiquimod; Inflammation; Interleukin-1; Interleukins; Intestinal Mucosa; Keratinocytes; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Plasma Cells; Psoriasis; RNA, Messenger; Skin; Synovial Membrane; Th17 Cells | 2016 |
Enhanced stability of tristetraprolin mRNA protects mice against immune-mediated inflammatory pathologies.
Topics: Aminoquinolines; Animals; Arthritis, Experimental; Cells, Cultured; Collagen; Dermatitis; Encephalomyelitis, Autoimmune, Experimental; Imiquimod; Inflammation; Mice; Mice, Transgenic; Mutation; RNA, Messenger; Tristetraprolin | 2016 |
Collagen-induced arthritis and imiquimod-induced psoriasis develop independently of interleukin-33.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Bone Resorption; Disease Models, Animal; Flow Cytometry; Fluorescent Antibody Technique; Imiquimod; Interleukin-33; Mice; Mice, Inbred C57BL; Mice, Knockout; Psoriasis | 2016 |